Palvella Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
PVLA
CUSIP
697947109
Type
Equity
Class
COM
Num filings
68
Total reported value, excl. options
$134 M
Manager Report Date Value ($000) Shares Option Type